Liégeois, Jean-François ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique
Seutin, Vincent ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Pharmacologie
Scuvée-Moreau, Jacqueline ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Pharmacologie - Département des sciences biomédicales et précliniques
Dresse, Albert ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
Bruhwyler, J.; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Geczy, J.
Delarge, Jacques
Damas, Jacques ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Language :
English
Title :
Influence of JL3, a potential antidepressant, on rat noradrenergic and serotonergic systems
Aghajanian G.K., Foote W.E., Sheard M.H. Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science. 161:1968;706-708.
Anderson C.D., Pasquier D.A., Forbes W.B., Morgane P.J. Locus coeruleus to dorsal raphe input examined by electrophysiological and morphological methods. Brain Res. 2:1977;209-221.
Baraban J.M., Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology. 19:1980;355-363.
Blier P., de Montigny C. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse. 1:1987;470-480.
Bruhwyler J., Liégeois J.-F., Chleide E., Rogister F., Damas J., Delarge J., Mercier M. New dibenzoazepine derivatives with disinhibitory/anxiolytic and/or antidepressant potential: behavioural study in the open-field and forced swimming tests. Behav. Pharmacol. 3:1995;567-579.
Gorea E., Adrien J. Serotonergic regulation of noradrenergic coerulean neurons/electrophysiological evidence for the involvement of 5-HT2 receptors. Eur. J. Pharmacol. 154:1988;285-291.
Guimaraes S., Trendelenburg U. Deviation and supersensitivity and inhibition of saturable site of loss. TiPS. 6:1985;371-374.
Haddjeri N., de Montigny C., Blier P. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system. Br. J. Pharmacol. 120:1997;865-875.
Iversen L.L. Drugs which affect the storage of noradrenaline. The actions of sympathomimetic amines. The Uptake and Storage of Noradrenaline in Sympathetic Nerves. 1967;181-186 Cambridge Univ. Press, Cambridge.
Liégeois J.-F., Rogister F., Bruhwyler J., Damas J., Nguyen T.P., Inarejos M.O., Chleide E., Mercier M., Delarge J. Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potent central nervous system agents: synthesis and neurochemical study. J. Med. Chem. 37:1994;519-525.
Liégeois J.-F., Scuvée-Moreau J., Giesberg I., Damas J., Bruhwyler J., Géczy J., Delarge J., Dresse A. Dibenzoazepine analogues: the electrophysiological properties of JL 3, a potential atypical antidepressant. Eur. J. Pharmacol. 310:1996;9-12.
Marwaha J., Aghajanian G.K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 222:1982;287-293.
Menkes D.B., Baraban J.M., Aghajanian G.K. Prazosin selectively antagonizes neuronal responses mediated by α1-adrenoceptors in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;273-275.
Quinaux N., Scuvée-Moreau J., Dresse A. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 319:1982;66-70.
Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., VanGompel P., Lesage A.S., DeLoore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-73.
Scuvée-Moreau J., Dresse A. Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat. Eur. J. Pharmacol. 57:1979;219-225.
Seutin V., Scuvée-Moreau J., Giesbers I., Massotte L., Dresse A. Effect of BHT920 on monoaminergic neurons of the rat brain: an electrophysiological in vivo and in vitro study. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;502-507.
Sprouse J.S., Aghajanian G.K. (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur. J. Pharmacol. 128:1986;295-298.
Sprouse J.S., Aghajanian G.K. Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1:1987;3-9.
Svensson T.H., Bunney B.S., Aghajanian G.K. Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine. Brain Res. 92:1975;291-306.
VanderMaelen C.P., Braselton J.P. Effects of a potential antipsychotic, BMY 14802, on firing of central serotonergic and noradrenergic neurons in rats. Eur. J. Pharmacol. 179:1990;357-366.
VanderMaelen C.P., Matheson G.K., Wilderman R.C., Patterson L.A. Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmacol. 129:1986;123-130.
Vergé D., Daval G., Patey A., Gozlan H., el Mestikawy S., Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur. J. Pharmacol. 113:1985;463-464.
Weissmann-Nanopoulos D., Mach E., Magre J., Demassey Y., Pujol J.F. Evidence for the localization of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7:1985;1061.
